← Leaderboards
Alexis E Traynor-Kaplan
Inologic, Inc.
$1,564,018
Attributed
$1,564,018
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $493.2K · FY2005–06$500K$375K$250K$125K$0
'05
'06
Funding mix
By agency
NIH$1,564,018 · 4
By mechanism
R44$1,285,132 · 2
R43$278,886 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Inositol Phosphates”
- Solomon H Snyder · Johns Hopkins University$13,667,016
- Philip W Majerus · Washington University$8,591,713
- Hongbo R Luo · Children'S Hospital Boston$8,561,531
- John D York · Duke University$6,501,272
- Richard A. Anderson · University Of Wisconsin-Madison$5,936,692
- Douglas C Eaton · Emory University$5,578,028
Research focus
Inositol PhosphatesCystic FibrosisChloride IonChloride ChannelsElectrophysiologyRespiratory EpitheliumDrug Screening /EvaluationEnzyme ActivityEnzyme MechanismEpidermal Growth FactorHuman SubjectHuman TissueInflammationIntracellular TransportIon TransportLaboratory MouseMembrane PermeabilityMetabolism Disorder ChemotherapyMonoclonal AntibodyPhosphatidylinositol 3 KinasePhosphatidylinositolsPhospholipase CPolymerase Chain ReactionPotassium Channel
Grant awards (5)
Preclinical Development of INO-4995 for Cystic Fibrosis$320,995
R44 · FY2006 · HL · contact PI
Preclinical Development of INO-4995 for Cystic Fibrosis$493,160
R44 · FY2005 · HL
NA, and C- flux regulation by a potential CF therapeut*$96,935
R43 · FY2002 · HL
Role of PKC XI in Cystic Fibrosis and other diseases$181,951
R43 · FY2001 · HL
INOSITOL PHOSPHATE REMEDIATION OF CL ION SECRETORY DEFEC$470,977
R44 · FY2000 · DK